The PIK3CA gene is mutated with high frequency in human breast cancers
暂无分享,去创建一个
Hiroyuki Konishi | Brock A. Peters | Victor E. Velculescu | Yardena Samuels | Pedram Argani | B. Peters | J. Ptak | V. Velculescu | P. Argani | Y. Samuels | N. Silliman | Steve Szabo | B. Park | K. Bachman | H. Konishi | B. Blair | B. Karakas | Bedri Karakas | Ben Ho Park | Kurtis E. Bachman | Natalie Silliman | Janine Ptak | Steve Szabo | Brian G. Blair | Clarence Lin | Clarence Lin | Yardena Samuels | Natalie Silliman | Janine Ptak
[1] P. Goss,et al. Estrogen and the risk of breast cancer. , 2001, The New England journal of medicine.
[2] J. Ptak,et al. High Frequency of Mutations of the PIK3CA Gene in Human Cancers , 2004, Science.
[3] A. Kornblihtt,et al. Mammary Epithelial-Mesenchymal Interaction Regulates Fibronectin Alternative Splicing via Phosphatidylinositol 3-Kinase* , 2004, Journal of Biological Chemistry.
[4] K. Kinzler,et al. Top-down morphogenesis of colorectal tumors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[5] C. Larabell,et al. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[6] H. Earp,et al. Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance. , 2004, International journal of radiation oncology, biology, physics.
[7] G. Mills,et al. HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells , 2003, Oncogene.
[8] Gordon B Mills,et al. Targeting the Phosphatidylinositol 3-Kinase / Akt Pathway for Enhancing Breast Cancer Cells to Radiotherapy 1 , 2003 .
[9] D. Radisky,et al. Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells , 2004, The Journal of cell biology.
[10] Lajos Pusztai,et al. Targeted Therapy in Breast Cancer , 2004, Molecular & Cellular Proteomics.
[11] V. Keshamouni,et al. Activation of the Pro-survival Phosphatidylinositol 3-Kinase/AKT Pathway by Transforming Growth Factor-β1 in Mesenchymal Cells Is Mediated by p38 MAPK-dependent Induction of an Autocrine Growth Factor* , 2004, Journal of Biological Chemistry.
[12] K. Ang,et al. Sensitization of breast cancer cells to radiation by trastuzumab. , 2003, Molecular cancer therapeutics.
[13] K. Svoboda,et al. PI‐3 kinase activity is required for epithelial‐mesenchymal transformation during palate fusion , 2002, Developmental dynamics : an official publication of the American Association of Anatomists.
[14] Joe W. Gray,et al. PIK3CA is implicated as an oncogene in ovarian cancer , 1999, Nature Genetics.
[15] Lewis C Cantley,et al. The phosphoinositide 3-kinase pathway. , 2002, Science.